Hedgehog Signal Transduction: Key Players, Oncogenic Drivers, and Cancer Therapy

Developmental Cell

Volumn 38, Issue 4, 2016, Pages 333-344

  Pak, Ekaterina ^a,b   Segal, Rosalind A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; KIF7 PROTEIN; KINESIN; PROTEIN PATCHED 1; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; SUPPRESSOR OF FUSED PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GLI; UNCLASSIFIED DRUG;

ANTERIOR POSTERIOR AXIS; BASAL CELL CARCINOMA; CANCER THERAPY; CELL MEMBRANE; CELL PROLIFERATION; CELL SURFACE; COMPARATIVE STUDY; DNA DAMAGE; EUKARYOTIC FLAGELLUM; FEEDBACK SYSTEM; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; LIGAND BINDING; LIPID RAFT; LYSOSOME; MEDULLOBLASTOMA; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; REPRESSOR GENE; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; ANIMAL; CELL TRANSFORMATION; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARCINOMA, BASAL CELL; CELL TRANSFORMATION, NEOPLASTIC; HEDGEHOG PROTEINS; HUMANS; MEDULLOBLASTOMA; MICE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84995468194     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2016.07.026     Document Type: Review

References (117)

1. Ahlfeld, J., Favaro, R., Pagella, P., Kretzschmar, H.A., Nicolis, S., Schuller, U., Sox2 requirement in sonic hedgehog-associated medulloblastoma. Cancer Res. 73 (2013), 3796–3807.
2. Amakye, D., Jagani, Z., Dorsch, M., Unraveling the therapeutic potential of the Hedgehog pathway in cancer. Nat. Med. 19 (2013), 1410–1422.
3. Arensdorf, A.M., Marada, S., Ogden, S.K., Smoothened regulation: a tale of two signals. Trends Pharmacol. Sci. 37 (2016), 62–72.
4. Atwood, S.X., Li, M., Lee, A., Tang, J.Y., Oro, A.E., GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas. Nature 494 (2013), 484–488.
5. Atwood, S.X., Sarin, K.Y., Whitson, R.J., Li, J.R., Kim, G., Rezaee, M., Ally, M.S., Kim, J., Yao, C., Chang, A.L., et al. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell 27 (2015), 342–353.
6. Bandopadhayay, P., Bergthold, G., Nguyen, B., Schubert, S., Gholamin, S., Tang, Y., Bolin, S., Schumacher, S.E., Zeid, R., Masoud, S., et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clin. Cancer Res. 20 (2014), 912–925.
7. Barakat, M.T., Humke, E.W., Scott, M.P., Learning from Jekyll to control Hyde: hedgehog signaling in development and cancer. Trends Mol. Med. 16 (2010), 337–348.
8. Basset-Seguin, N., Hauschild, A., Grob, J.-J., Kunstfeld, R., Dréno, B., Mortier, L., Ascierto, P.A., Licitra, L., Dutriaux, C., Thomas, L., et al. Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. Lancet Oncol. 16 (2015), 729–736.
9. Batora, N.V., Sturm, D., Jones, D.T., Kool, M., Pfister, S.M., Northcott, P.A., Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics. Neuroscience 264 (2014), 171–185.
10. Beachy, P.A., Hymowitz, S.G., Lazarus, R.A., Leahy, D.J., Siebold, C., Interactions between Hedgehog proteins and their binding partners come into view. Genes Dev. 24 (2010), 2001–2012.
11. Bijlsma, M.F., Spek, C.A., Zivkovic, D., van de Water, S., Rezaee, F., Peppelenbosch, M.P., Repression of smoothened by patched-dependent (pro-)vitamin D3 secretion. PLoS Biol., 4, 2006, e232.
12. Bonilla, X., Parmentier, L., King, B., Bezrukov, F., Kaya, G., Zoete, V., Seplyarskiy, V.B., Sharpe, H.J., McKee, T., Letourneau, A., et al. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nat. Genet. 48 (2016), 398–406.
13. Bosco-Clement, G., Zhang, F., Chen, Z., Zhou, H.M., Li, H., Mikami, I., Hirata, T., Yagui-Beltran, A., Lui, N., Do, H.T., et al. Targeting Gli transcription activation by small molecule suppresses tumor growth. Oncogene 33 (2014), 2087–2097.
14. Buonamici, S., Williams, J., Morrissey, M., Wang, A., Guo, R., Vattay, A., Hsiao, K., Yuan, J., Green, J., Ospina, B., et al. Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma. Sci. Transl. Med., 2, 2010, 51ra70.
15. Chavez, M., Ena, S., Van Sande, J., de Kerchove d'Exaerde, A., Schurmans, S., Schiffmann, S.N., Modulation of ciliary phosphoinositide content regulates trafficking and sonic hedgehog signaling output. Dev. Cell 34 (2015), 338–350.
16. Chen, Y., Jiang, J., Decoding the phosphorylation code in Hedgehog signal transduction. Cell Res. 23 (2013), 186–200.
17. Chen, Y., Struhl, G., Dual roles for patched in sequestering and transducing hedgehog. Cell 87 (1996), 553–563.
18. Chen, M.H., Wilson, C.W., Li, Y.J., Law, K.K., Lu, C.S., Gacayan, R., Zhang, X., Hui, C.C., Chuang, P.T., Cilium-independent regulation of Gli protein function by Sufu in Hedgehog signaling is evolutionarily conserved. Genes Dev. 23 (2009), 1910–1928.
19. Chen, Y., Sasai, N., Ma, G., Yue, T., Jia, J., Briscoe, J., Jiang, J., Sonic Hedgehog dependent phosphorylation by CK1alpha and GRK2 is required for ciliary accumulation and activation of smoothened. PLoS Biol., 9, 2011, e1001083.
20. Chen, Y., Yue, S., Xie, L., Pu, X.H., Jin, T., Cheng, S.Y., Dual Phosphorylation of suppressor of fused (Sufu) by PKA and GSK3beta regulates its stability and localization in the primary cilium. J. Biol. Chem. 286 (2011), 13502–13511.
21. Cheung, H.O.L., Zhang, X., Ribeiro, A., Mo, R., Makino, S., Puviindran, V., Law, K.K.L., Briscoe, J., Hui, C.C., The kinesin protein Kif7 is a critical regulator of gli transcription factors in mammalian hedgehog signaling. Sci. Signal., 2, 2009, ra29.
22. Chong, Y.C., Mann, R.K., Zhao, C., Kato, M., Beachy, P.A., Bifurcating action of Smoothened in Hedgehog signaling is mediated by Dlg5. Genes Dev. 29 (2015), 262–276.
23. Di Magno, L., Basile, A., Coni, S., Manni, S., Sdruscia, G., D'Amico, D., Antonucci, L., Infante, P., De Smaele, E., Cucchi, D., et al. The energy sensor AMPK regulates Hedgehog signaling in human cells through a unique Gli1 metabolic checkpoint. Oncotarget 7 (2016), 9538–9549.
24. Eisner, A., Pazyra-Murphy, M.F., Durresi, E., Zhou, P., Zhao, X., Chadwick, E.C., Xu, P.X., Hillman, R.T., Scott, M.P., Greenberg, M.E., et al. The Eya1 phosphatase promotes Shh signaling during hindbrain development and oncogenesis. Dev. Cell 33 (2015), 22–35.
25. Endoh-Yamagami, S., Evangelista, M., Wilson, D., Wen, X., Theunissen, J.W., Phamluong, K., Davis, M., Scales, S.J., Solloway, M.J., de Sauvage, F.J., et al. The mammalian Cos2 homolog Kif7 plays an essential role in modulating Hh signal transduction during development. Curr. Biol. 19 (2009), 1320–1326.
26. Franco, I., Gulluni, F., Campa, C.C., Costa, C., Margaria, J.P., Ciraolo, E., Martini, M., Monteyne, D., De Luca, E., Germena, G., et al. PI3K class II alpha controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function. Dev. Cell 28 (2014), 647–658.
27. Gajjar, A., Stewart, C.F., Ellison, D.W., Kaste, S., Kun, L.E., Packer, R.J., Goldman, S., Chintagumpala, M., Wallace, D., Takebe, N., et al. Phase I study of vismodegib in children with recurrent or refractory medulloblastoma: a pediatric brain tumor consortium study. Clin. Cancer Res. 19 (2013), 6305–6312.
28. Garcia-Gonzalo, F.R., Phua, S.C., Roberson, E.C., Garcia, G. 3rd, Abedin, M., Schurmans, S., Inoue, T., Reiter, J.F., Phosphoinositides regulate ciliary protein trafficking to modulate hedgehog signaling. Dev. Cell 34 (2015), 400–409.
29. Ge, X., Milenkovic, L., Suyama, K., Hartl, T., Purzner, T., Winans, A., Meyer, T., Scott, M.P., Phosphodiesterase 4D acts downstream of neuropilin to control hedgehog signal transduction and the growth of medulloblastoma. Elife, 4, 2015, e07068, 10.7554/eLife.07068.
30. Goetz, S.C., Anderson, K.V., The primary cilium: a signalling centre during vertebrate development. Nat. Rev. Genet. 11 (2010), 331–344.
31. Goodrich, L.V., Milenkovic, L., Higgins, K.M., Scott, M.P., Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277 (1997), 1109–1113.
32. Hahn, H., Wicking, C., Zaphiropoulous, P.G., Gailani, M.R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A.B., Gillies, S., et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85 (1996), 841–851.
33. Hatton, B.A., Knoepfler, P.S., Kenney, A.M., Rowitch, D.H., de Alboran, I.M., Olson, J.M., Eisenman, R.N., N-myc is an essential downstream effector of Shh signaling during both normal and neoplastic cerebellar growth. Cancer Res. 66 (2006), 8655–8661.
34. Hatton, B.A., Villavicencio, E.H., Tsuchiya, K.D., Pritchard, J.I., Ditzler, S., Pullar, B., Hansen, S., Knoblaugh, S.E., Lee, D., Eberhart, C.G., et al. The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread. Cancer Res. 68 (2008), 1768–1776.
35. He, M., Subramanian, R., Bangs, F., Omelchenko, T., Liem, K.F. Jr., Kapoor, T.M., Anderson, K.V., The kinesin-4 protein Kif7 regulates mammalian Hedgehog signalling by organizing the cilium tip compartment. Nat. Cell Biol. 16 (2014), 663–672.
36. He, X., Zhang, L., Chen, Y., Remke, M., Shih, D., Lu, F., Wang, H., Deng, Y., Yu, Y., Xia, Y., et al. The G protein alpha subunit Galphas is a tumor suppressor in Sonic hedgehog-driven medulloblastoma. Nat. Med. 20 (2014), 1035–1042.
37. Hillman, R.T., Feng, B.Y., Ni, J., Woo, W.M., Milenkovic, L., Hayden Gephart, M.G., Teruel, M.N., Oro, A.E., Chen, J.K., Scott, M.P., Neuropilins are positive regulators of Hedgehog signal transduction. Genes Dev. 25 (2011), 2333–2346.
38. Huh, J.Y., Kwon, M.J., Seo, K.Y., Kim, M.K., Chae, K.Y., Kim, S.H., Ki, C.S., Yoon, M.S., Kim, D.H., Novel nonsense GNAS mutation in a 14-month-old boy with plate-like osteoma cutis and medulloblastoma. J. Dermatol. 41 (2014), 319–321.
39. Hui, C.C., Angers, S., Gli proteins in development and disease. Annu. Rev. Cell Dev. Biol. 27 (2011), 513–537.
40. Humke, E.W., Dorn, K.V., Milenkovic, L., Scott, M.P., Rohatgi, R., The output of Hedgehog signaling is controlled by the dynamic association between Suppressor of Fused and the Gli proteins. Genes Dev. 24 (2010), 670–682.
41. Iglesias-Bartolome, R., Torres, D., Marone, R., Feng, X., Martin, D., Simaan, M., Chen, M., Weinstein, L.S., Taylor, S.S., Molinolo, A.A., et al. Inactivation of a Galpha(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat. Cell Biol. 17 (2015), 793–803.
42. Incardona, J.P., Lee, J.H., Robertson, C.P., Enga, K., Kapur, R.P., Roelink, H., Receptor-mediated endocytosis of soluble and membrane-tethered Sonic hedgehog by Patched-1. Proc. Natl. Acad. Sci. USA 97 (2000), 12044–12049.
43. Ingham, P.W., McMahon, A.P., Hedgehog signaling in animal development: paradigms and principles. Genes Dev. 15 (2001), 3059–3087.
44. Jayaraman, S.S., Rayhan, D.J., Hazany, S., Kolodney, M.S., Mutational landscape of basal cell carcinomas by whole-exome sequencing. J. Invest. Dermatol. 134 (2014), 213–220.
45. Jimeno, A., Weiss, G.J., Miller, W.H. Jr., Gettinger, S., Eigl, B.J., Chang, A.L., Dunbar, J., Devens, S., Faia, K., Skliris, G., et al. Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors. Clin. Cancer Res. 19 (2013), 2766–2774.
46. Johnson, R.L., Rothman, A.L., Xie, J., Goodrich, L.V., Bare, J.W., Bonifas, J.M., Quinn, A.G., Myers, R.M., Cox, D.R., Epstein, E.H. Jr., et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272 (1996), 1668–1671.
47. Kenney, A.M., Cole, M.D., Rowitch, D.H., Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 130 (2003), 15–28.
48. Khaliullina, H., Bilgin, M., Sampaio, J.L., Shevchenko, A., Eaton, S., Endocannabinoids are conserved inhibitors of the Hedgehog pathway. Proc. Natl. Acad. Sci. USA 112 (2015), 3415–3420.
49. Kim, J., Tang, J.Y., Gong, R., Kim, J., Lee, J.J., Clemons, K.V., Chong, C.R., Chang, K.S., Fereshteh, M., Gardner, D., et al. Itraconazole, a commonly used antifungal that inhibits Hedgehog pathway activity and cancer growth. Cancer Cell 17 (2010), 388–399.
50. Kim, J., Lee, J.J., Kim, J., Gardner, D., Beachy, P.A., Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector. Proc. Natl. Acad. Sci. USA 107 (2010), 13432–13437.
51. Kim, J., Aftab, B.T., Tang, J.Y., Kim, D., Lee, A.H., Rezaee, M., Kim, J., Chen, B., King, E.M., Borodovsky, A., et al. Itraconazole and arsenic trioxide inhibit Hedgehog pathway activation and tumor growth associated with acquired resistance to smoothened antagonists. Cancer Cell 23 (2013), 23–34.
52. Kimura, H., Ng, J.M., Curran, T., Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell 13 (2008), 249–260.
53. Kool, M., Jones, D.T., Jager, N., Northcott, P.A., Pugh, T.J., Hovestadt, V., Piro, R.M., Esparza, L.A., Markant, S.L., Remke, M., et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25 (2014), 393–405.
54. Lauth, M., Bergstrom, A., Shimokawa, T., Toftgard, R., Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl. Acad. Sci. USA 104 (2007), 8455–8460.
55. Lee, Y., Kawagoe, R., Sasai, K., Li, Y., Russell, H.R., Curran, T., McKinnon, P.J., Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 26 (2007), 6442–6447.
56. Lee, J.J., Perera, R.M., Wang, H., Wu, D.C., Liu, X.S., Han, S., Fitamant, J., Jones, P.D., Ghanta, K.S., Kawano, S., et al. Stromal response to Hedgehog signaling restrains pancreatic cancer progression. Proc. Natl. Acad. Sci. USA 111 (2014), E3091–E3100.
57. Lee, S.T., Welch, K.D., Panter, K.E., Gardner, D.R., Garrossian, M., Chang, C.W., Cyclopamine: from cyclops lambs to cancer treatment. J. Agric. Food Chem. 62 (2014), 7355–7362.
58. Li, Z.J., Mack, S.C., Mak, T.H., Angers, S., Taylor, M.D., Hui, C.C., Evasion of p53 and G2/M checkpoints are characteristic of Hh-driven basal cell carcinoma. Oncogene 33 (2014), 2674–2680.
59. Li, Y.H., Luo, J., Mosley, Y.Y., Hedrick, V.E., Paul, L.N., Chang, J., Zhang, G., Wang, Y.K., Banko, M.R., Brunet, A., et al. AMP-activated protein kinase directly phosphorylates and destabilizes Hedgehog pathway transcription factor GLI1 in medulloblastoma. Cell Rep. 12 (2015), 599–609.
60. Liem, K.F. Jr., He, M., Ocbina, P.J., Anderson, K.V., Mouse Kif7/Costal2 is a cilia-associated protein that regulates Sonic hedgehog signaling. Proc. Natl. Acad. Sci. USA 106 (2009), 13377–13382.
61. Lin, C., Yao, E., Wang, K., Nozawa, Y., Shimizu, H., Johnson, J.R., Chen, J.N., Krogan, N.J., Chuang, P.T., Regulation of Sufu activity by p66beta and Mycbp provides new insight into vertebrate Hedgehog signaling. Genes Dev. 28 (2014), 2547–2563.
62. Lin, C.Y., Erkek, S., Tong, Y., Yin, L., Federation, A.J., Zapatka, M., Haldipur, P., Kawauchi, D., Risch, T., Warnatz, H.J., et al. Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature 530 (2016), 57–62.
63. Liu, Y.C., Couzens, A.L., Deshwar, A.R., McBroom-Cerajewski, L.D.B., Zhang, X., Puviindran, V., Scott, I.C., Gingras, A.C., Hui, C.C., Angers, S., The PPFIA1-PP2A protein complex promotes trafficking of Kif7 to the ciliary tip and Hedgehog signaling. Sci. Signal., 7, 2014, ra117.
64. Long, J., Li, B., Rodriguez-Blanco, J., Pastori, C., Volmar, C.H., Wahlestedt, C., Capobianco, A., Bai, F., Pei, X.H., Ayad, N.G., et al. The BET bromodomain inhibitor I-BET151 acts downstream of smoothened protein to abrogate the growth of hedgehog protein-driven cancers. J. Biol. Chem. 289 (2014), 35494–35502.
65. Marigo, V., Davey, R.A., Zuo, Y., Cunningham, J.M., Tabin, C.J., Biochemical evidence that patched is the hedgehog receptor. Nature 384 (1996), 176–179.
66. Mas, C., Ruiz i Altaba, A., Small molecule modulation of HH-GLI signaling: current leads, trials and tribulations. Biochem. Pharmacol. 80 (2010), 712–723.
67. Mathew, E., Zhang, Y., Holtz, A.M., Kane, K.T., Song, J.Y., Allen, B.L., Pasca di Magliano, M., Dosage-dependent regulation of pancreatic cancer growth and angiogenesis by hedgehog signaling. Cell Rep. 9 (2014), 484–494.
68. Metcalfe, C., Alicke, B., Crow, A., Lamoureux, M., Dijkgraaf, G.J., Peale, F., Gould, S.E., de Sauvage, F.J., PTEN loss mitigates the response of medulloblastoma to Hedgehog pathway inhibition. Cancer Res. 73 (2013), 7034–7042.
69. Migden, M.R., Guminski, A., Gutzmer, R., Dirix, L., Lewis, K.D., Combemale, P., Herd, R.M., Kudchadkar, R., Trefzer, U., Gogov, S., et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 16 (2015), 716–728.
70. Mille, F., Tamayo-Orrego, L., Levesque, M., Remke, M., Korshunov, A., Cardin, J., Bouchard, N., Izzi, L., Kool, M., Northcott, P.A., et al. The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumors. Dev. Cell 31 (2014), 34–47.
71. Mukhopadhyay, S., Wen, X., Ratti, N., Loktev, A., Rangell, L., Scales, S.J., Jackson, P.K., The ciliary G-protein-coupled receptor Gpr161 negatively regulates the Sonic hedgehog pathway via cAMP signaling. Cell 152 (2013), 210–223.
72. Murone, M., Rosenthal, A., de Sauvage, F.J., Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr. Biol. 9 (1999), 76–84.
73. Myers, B.R., Sever, N., Chong, Y.C., Kim, J., Belani, J.D., Rychnovsky, S., Bazan, J.F., Beachy, P.A., Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response. Dev. Cell 26 (2013), 346–357.
74. Nachtergaele, S., Whalen, D.M., Mydock, L.K., Zhao, Z., Malinauskas, T., Krishnan, K., Ingham, P.W., Covey, D.F., Siebold, C., Rohatgi, R., Structure and function of the Smoothened extracellular domain in vertebrate Hedgehog signaling. Elife, 2, 2013, e01340.
75. Nedelcu, D., Liu, J., Xu, Y., Jao, C., Salic, A., Oxysterol binding to the extracellular domain of smoothened in Hedgehog signaling. Nat. Chem. Biol. 9 (2013), 557–564.
76. Niewiadomski, P., Kong, J.H., Ahrends, R., Ma, Y., Humke, E.W., Khan, S., Teruel, M.N., Novitch, B.G., Rohatgi, R., Gli protein activity is controlled by multisite phosphorylation in vertebrate Hedgehog signaling. Cell Rep. 6 (2014), 168–181.
77. Nitzki, F., Becker, M., Frommhold, A., Schulz-Schaeffer, W., Hahn, H., Patched knockout mouse models of basal cell carcinoma. J. Skin Cancer, 2012, 2012, 907543.
78. Northcott, P.A., Hielscher, T., Dubuc, A., Mack, S., Shih, D., Remke, M., Al-Halabi, H., Albrecht, S., Jabado, N., Eberhart, C.G., et al. Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol. 122 (2011), 231–240.
79. Nozawa, Y.I., Lin, C., Chuang, P.T., Hedgehog signaling from the primary cilium to the nucleus: an emerging picture of ciliary localization, trafficking and transduction. Curr. Opin. Genet. Dev. 23 (2013), 429–437.
80. Pagliarini, R., Shao, W., Sellers, W.R., Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure. EMBO Rep. 16 (2015), 280–296.
81. Pal, K., Hwang, S.H., Somatilaka, B., Badgandi, H., Jackson, P.K., DeFea, K., Mukhopadhyay, S., Smoothened determines beta-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium. J. Cell Biol. 212 (2016), 861–875.
82. Pan, Y., Wang, B., A novel protein-processing domain in Gli2 and Gli3 differentially blocks complete protein degradation by the proteasome. J. Biol. Chem. 282 (2007), 10846–10852.
83. Pan, Y., Bai, C.B., Joyner, A.L., Wang, B., Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol. Cell Biol. 26 (2006), 3365–3377.
84. Pan, Y., Wang, C., Wang, B., Phosphorylation of Gli2 by protein kinase A is required for Gli2 processing and degradation and the Sonic Hedgehog-regulated mouse development. Dev. Biol. 326 (2009), 177–189.
85. Pearse, R.V. II, Collier, L.S., Scott, M.P., Tabin, C.J., Vertebrate homologs of Drosophila suppressor of fused Interact with the gli family of transcriptional regulators. Dev. Biol. 212 (1999), 323–336.
86. Pusapati, G.V., Hughes, C.E., Dorn, K.V., Zhang, D., Sugianto, P., Aravind, L., Rohatgi, R., EFCAB7 and IQCE regulate hedgehog signaling by tethering the EVC-EVC2 complex to the base of primary cilia. Dev. Cell 28 (2014), 483–496.
87. Rausch, T., Jones, D.T., Zapatka, M., Stutz, A.M., Zichner, T., Weischenfeldt, J., Jager, N., Remke, M., Shih, D., Northcott, P.A., et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148 (2012), 59–71.
88. Robinson, G.W., Orr, B.A., Wu, G., Gururangan, S., Lin, T., Qaddoumi, I., Packer, R.J., Goldman, S., Prados, M.D., Desjardins, A., et al. Vismodegib exerts targeted efficacy against recurrent sonic hedgehog-subgroup medulloblastoma: results from phase II pediatric brain tumor consortium studies PBTC-025B and PBTC-032. J. Clin. Oncol. 33 (2015), 2646–2654.
89. Rodon, J., Tawbi, H.A., Thomas, A.L., Stoller, R.G., Turtschi, C.P., Baselga, J., Sarantopoulos, J., Mahalingam, D., Shou, Y., Moles, M.A., et al. A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumors. Clin. Cancer Res. 20 (2014), 1900–1909.
90. Romer, J.T., Kimura, H., Magdaleno, S., Sasai, K., Fuller, C., Baines, H., Connelly, M., Stewart, C.F., Gould, S., Rubin, L.L., et al. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell 6 (2004), 229–240.
91. Rudin, C.M., Hann, C.L., Laterra, J., Yauch, R.L., Callahan, C.A., Fu, L., Holcomb, T., Stinson, J., Gould, S.E., Coleman, B., et al. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N. Engl. J. Med. 361 (2009), 1173–1178.
92. Scales, S.J., de Sauvage, F.J., Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol. Sci. 30 (2009), 303–312.
93. Sekulic, A., Von Hoff, D., Hedgehog pathway inhibition. Cell, 164, 2016, 831.
94. Sekulic, A., Migden, M.R., Oro, A.E., Dirix, L., Lewis, K.D., Hainsworth, J.D., Solomon, J.A., Yoo, S., Arron, S.T., Friedlander, P.A., et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N. Engl. J. Med. 366 (2012), 2171–2179.
95. Sekulic, A., Migden, M.R., Lewis, K., Hainsworth, J.D., Solomon, J.A., Yoo, S., Arron, S.T., Friedlander, P.A., Marmur, E., Rudin, C.M., et al. Pivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCC. J. Am. Acad. Dermatol. 72 (2015), 1021–1026.e1028.
96. Sharpe, H.J., Pau, G., Dijkgraaf, G.J., Basset-Seguin, N., Modrusan, Z., Januario, T., Tsui, V., Durham, A.B., Dlugosz, A.A., Haverty, P.M., et al. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell 27 (2015), 327–341.
97. Shi, X., Zhang, Z., Zhan, X., Cao, M., Satoh, T., Akira, S., Shpargel, K., Magnuson, T., Li, Q., Wang, R., et al. An epigenetic switch induced by Shh signalling regulates gene activation during development and medulloblastoma growth. Nat. Commun., 5, 2014, 5425.
98. Singh, A.R., Joshi, S., Zulcic, M., Alcaraz, M., Garlich, J.R., Morales, G.A., Cho, Y.J., Bao, L., Levy, M.L., Newbury, R., et al. PI-3K inhibitors preferentially target cd15+ cancer stem cell population in SHH driven medulloblastoma. PLoS One, 11, 2016, e0150836.
99. Smith, M.J., Beetz, C., Williams, S.G., Bhaskar, S.S., O'Sullivan, J., Anderson, B., Daly, S.B., Urquhart, J.E., Bholah, Z., Oudit, D., et al. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations. J. Clin. Oncol. 32 (2014), 4155–4161.
100. Stone, D.M., Hynes, M., Armanini, M., Swanson, T.A., Gu, Q., Johnson, R.L., Scott, M.P., Pennica, D., Goddard, A., Phillips, H., et al. The tumour-suppressor gene patched encodes a candidate receptor for sonic hedgehog. Nature 384 (1996), 129–134.
101. Stone, D.M., Murone, M., Luoh, S., Ye, W., Armanini, M.P., Gurney, A., Phillips, H., Brush, J., Goddard, A., de Sauvage, F.J., et al. Characterization of the human suppressor of fused, a negative regulator of the zinc-finger transcription factor Gli. J. Cell Sci. 112 (1999), 4437–4448.
102. Taipale, J., Cooper, M.K., Maiti, T., Beachy, P.A., Patched acts catalytically to suppress the activity of Smoothened. Nature 418 (2002), 892–897.
103. Tang, Y., Gholamin, S., Schubert, S., Willardson, M.I., Lee, A., Bandopadhayay, P., Bergthold, G., Masoud, S., Nguyen, B., Vue, N., et al. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nat. Med. 20 (2014), 732–740.
104. Tay, S.Y., Ingham, P.W., Roy, S., A homologue of the Drosophila kinesin-like protein Costal2 regulates Hedgehog signal transduction in the vertebrate embryo. Development 132 (2005), 625–634.
105. Taylor, M.D., Northcott, P.A., Korshunov, A., Remke, M., Cho, Y.J., Clifford, S.C., Eberhart, C.G., Parsons, D.W., Rutkowski, S., Gajjar, A., et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123 (2012), 465–472.
106. Teglund, S., Toftgard, R., Hedgehog beyond medulloblastoma and basal cell carcinoma. Biochim. Biophys. Acta 1805 (2010), 181–208.
107. Tempé, D., Casas, M., Karaz, S., Blanchet-Tournier, M.F., Concordet, J.P., Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Mol. Cell Biol. 26 (2006), 4316–4326.
108. Tian, H., Callahan, C.A., DuPree, K.J., Darbonne, W.C., Ahn, C.P., Scales, S.J., de Sauvage, F.J., Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc. Natl. Acad. Sci. USA 106 (2009), 4254–4259.
109. Vanner, R.J., Remke, M., Gallo, M., Selvadurai, H.J., Coutinho, F., Lee, L., Kushida, M., Head, R., Morrissy, S., Zhu, X., et al. Quiescent sox2(+) cells drive hierarchical growth and relapse in sonic hedgehog subgroup medulloblastoma. Cancer Cell 26 (2014), 33–47.
110. Wang, B., Li, Y., Evidence for the direct involvement of {beta}TrCP in Gli3 protein processing. Proc. Natl. Acad. Sci. USA 103 (2006), 33–38.
111. Wang, C., Pan, Y., Wang, B., Suppressor of fused and Spop regulate the stability, processing and function of Gli2 and Gli3 full-length activators but not their repressors. Development 137 (2010), 2001–2009.
112. Wechsler-Reya, R.J., Scott, M.P., Control of neuronal precursor proliferation in the cerebellum by sonic hedgehog. Neuron 22 (1999), 103–114.
113. Xie, J., Murone, M., Luoh, S.M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J.M., Lam, C.W., Hynes, M., Goddard, A., et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391 (1998), 90–92.
114. Yauch, R.L., Dijkgraaf, G.J., Alicke, B., Januario, T., Ahn, C.P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C.A., Tang, T., et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science 326 (2009), 572–574.
115. Yue, S., Tang, L., Tang, Y., Tang, Y., Shen, Q., Ding, J., Chen, Y., Zhang, Z., Yu, T., Zhang, Y.E., et al. Requirement of Smurf-mediated endocytosis of patched1 in sonic hedgehog signal reception. Elife, 3, 2014, e02555.
116. Zhao, X., Ponomaryov, T., Ornell, K.J., Zhou, P., Dabral, S.K., Pak, E., Li, W., Atwood, S.X., Whitson, R.J., Chang, A.L., et al. RAS/MAPK activation drives resistance to smo inhibition, metastasis, and tumor evolution in shh pathway-dependent tumors. Cancer Res. 75 (2015), 3623–3635.
117. Zhukova, N., Ramaswamy, V., Remke, M., Pfaff, E., Shih, D.J., Martin, D.C., Castelo-Branco, P., Baskin, B., Ray, P.N., Bouffet, E., et al. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J. Clin. Oncol. 31 (2013), 2927–2935.